Anixa Biosciences Inc (ANIX) has 94 open-market insider trades by 7 insiders since 2018. Over the last six months insiders net bought $430K. The most active filer is Lewis H. Titterton Jr., Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Lewis H. Titterton Jr. | Dir | — | 38 | $2.1M | 2026-09-23 |
| Amit Kumar | CEO | — | 31 | $1.1M | 2026-09-24 |
| Arnold M. Baskies | Dir | — | 14 | $498K | 2026-09-24 |
| Emily Gottschalk | Dir | — | 3 | $280K | 2021-07-15 |
| Michael Catelani | PresCOOCFO | — | 6 | $92K | 2026-09-30 |
| David Cavalier | Dir | — | 1 | $8K | 2019-04-29 |
| John J. Monahan | Dir | — | 1 | $4K | 2019-04-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael Catelani | President & COO +1 | Buy | $16K | 2026-09-30 |
| Arnold M. Baskies | Director | Buy | $14K | 2026-09-24 |
| Amit Kumar | CEO | Buy | $19K | 2026-09-24 |
| Lewis H. Titterton Jr. | Director | Buy | $132K | 2026-09-23 |
| Lewis H. Titterton Jr. | Director | Buy | $27K | 2026-09-10 |
| Amit Kumar | CEO | Buy | $8K | 2026-09-10 |
Companies that share insiders with ANIX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Amit Kumar | CEO | Buy | $14K | 2026-09-10 |
| Amit Kumar | CEO | Buy | $17K | 2026-07-31 |
| Amit Kumar | CEO | Buy | $11K | 2026-07-27 |
| Amit Kumar | CEO | Buy | $17K | 2026-07-27 |
| Amit Kumar | CEO | Buy | $11K | 2026-07-24 |
| Amit Kumar | CEO | Buy | $17K | 2026-07-20 |
| Lewis H. Titterton Jr. | Director | Buy | $42K | 2026-07-20 |
| Lewis H. Titterton Jr. | Director | Buy | $9K | 2026-07-15 |
| Amit Kumar | CEO | Buy | $15K | 2026-07-10 |